Treatment With Recombinant Placental Growth Factor (PlGF) Enhances Both Angiogenesis and Arteriogenesis and Improves Survival After Myocardial Infarction-Reference-Cited by-同舟云学术

Treatment With Recombinant Placental Growth Factor (PlGF) Enhances Both Angiogenesis and Arteriogenesis and Improves Survival After Myocardial Infarction

Published:2009 Issue:9 Volume:73 Page:1674-1682
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Takeda Yukiji¹,Uemura Shiro¹,Iwama Hajime¹,Imagawa Kei-ichi¹,Nishida Taku¹,Onoue Kenji¹,Takemoto Yasuhiro¹,Soeda Tsunenari¹,Okayama Satoshi¹,Somekawa Satoshi¹,Ishigami Ken-ichi¹,Takaoka Minoru¹,Kawata Hiroyuki¹,Kubo Atsushi¹,Horii Manabu¹,Nakajima Tamio¹,Saito Yoshihiko¹

Affiliation:

1. First Department of Internal Medicine, Nara Medical University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/73/9/73_CJ-08-1067/_pdf

Reference35 articles.

1. 1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161-1172.

2. 2. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): Mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003; 108: 2212-2218.

3. 3. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221.